| 1. |
1. Jain KK. Transdermal drug delivery: technologies, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1–230.
|
| |
| 2. |
2. Mainardes RM, Urban MC, Cinto PO, et al. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
Curr Drug Deliv 2006;3:275–85.
|
| |
| 3. |
3. Van den Mooter G. Colon drug delivery. Expert Opin Drug Deliv 2006;3:111–25.
|
| |
| 4. |
4. Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics
for systemic delivery. Adv Drug Deliv Rev 2006;58:1030–60.
|
| |
| 5. |
5. Ely L, Roa W, Finlay WH, Lobenberg R. Effervescent dry powder for respiratory drug delivery. Eur J Pharm Biopharm 2007;65:346–53.
|
| |
| 6. |
6. Dailey LA, Jekel N, Fink L, et al. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery
systems in the lung. Toxicol Appl Pharmacol 2006;215:100–8.
|
| |
| 7. |
7. Jain KK. Cardiovascular drug delivery: technologies, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1–230.
|
| |
| 8. |
8. Jain KK. Drug delivery in CNS disorders: technologies, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1–310.
|
| |
| 9. |
9. Groisman A, Enzelberger M, Quake SR. Microfluidic memory and control devices. Science 2003;300:955–8.
|
| |
| 10. |
10. Yih TC, Wei C, Hammad B. Modeling and characterization of a nanoliter drug-delivery MEMS micropump with circular bossed
membrane. Nanomedicine 2005;1:164–75.
|
| |
| 11. |
11. Prescott JH, Lipka S, Baldwin S, et al. Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip
device. Nat Biotechnol 2006;24:437–8.
|
| |
| 12. |
12. Chitkara D, Shikanov A, Kumar N, Domb AJ. Biodegradable injectable in situ depot-forming drug delivery systems. Macromol
Biosci 2006;6:977–90.
|
| |
| 13. |
13. Jain KK. Nanobiotechnology: applications, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1–690.
|
| |
| 14. |
14. Vila A, Gill H, McCallion O, Alonso MJ. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size
and PEG coating density. J Control Release 2004;98:231–44.
|
| |
| 15. |
15. Xu Y, Du Y, Huang R, Gao L. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 2003;24:5015–22.
|
| |
| 16. |
16. Dufresne MH, Le Garrec D, Sant V, et al. Preparation and characterization of water-soluble pH-sensitive nanocarriers for
drug delivery. Int J Pharm 2004;277:81–90.
|
| |
| 17. |
17. Matsumura Y. Micelle carrier system in clinical trial. Nippon Rinsho 2006;64:316–21.
|
| |
| 18. |
18. Jain KK. Personalized medicine: scientific and commercial aspects. Basel: Jain PharmaBiotech Publications, 2007:1–570.
|
| |
| 19. |
19. Gorbacheva VY, Kondratov RV, Zhang R, et al. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends
on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci USA 2005;102:3407–12.
|
| |
| 20. |
20. Jain KK. Drug delivery in cancer: technologies, markets and companies. Basel: Jain PharmaBiotech Publications, 2008:1–550.
|
| |